Cargando…
4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966809/ https://www.ncbi.nlm.nih.gov/pubmed/33727525 http://dx.doi.org/10.1038/s41408-021-00455-x |
| _version_ | 1783665740999557120 |
|---|---|
| author | Jiao, Cheng Zvonkov, Eugene Lai, Xun Zhang, Rui Liu, Yuchen Qin, Yue Savchenko, Valery Gabeeva, Nelly Chung, Tsai-Hua Sheng, Liyuan Chang, Lung-Ji |
| author_facet | Jiao, Cheng Zvonkov, Eugene Lai, Xun Zhang, Rui Liu, Yuchen Qin, Yue Savchenko, Valery Gabeeva, Nelly Chung, Tsai-Hua Sheng, Liyuan Chang, Lung-Ji |
| author_sort | Jiao, Cheng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7966809 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79668092021-04-01 4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas Jiao, Cheng Zvonkov, Eugene Lai, Xun Zhang, Rui Liu, Yuchen Qin, Yue Savchenko, Valery Gabeeva, Nelly Chung, Tsai-Hua Sheng, Liyuan Chang, Lung-Ji Blood Cancer J Correspondence Nature Publishing Group UK 2021-03-17 /pmc/articles/PMC7966809/ /pubmed/33727525 http://dx.doi.org/10.1038/s41408-021-00455-x Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Jiao, Cheng Zvonkov, Eugene Lai, Xun Zhang, Rui Liu, Yuchen Qin, Yue Savchenko, Valery Gabeeva, Nelly Chung, Tsai-Hua Sheng, Liyuan Chang, Lung-Ji 4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas |
| title | 4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas |
| title_full | 4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas |
| title_fullStr | 4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas |
| title_full_unstemmed | 4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas |
| title_short | 4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas |
| title_sort | 4scar2.0: a multi-car-t therapy regimen for the treatment of relapsed/refractory b cell lymphomas |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966809/ https://www.ncbi.nlm.nih.gov/pubmed/33727525 http://dx.doi.org/10.1038/s41408-021-00455-x |
| work_keys_str_mv | AT jiaocheng 4scar20amulticarttherapyregimenforthetreatmentofrelapsedrefractorybcelllymphomas AT zvonkoveugene 4scar20amulticarttherapyregimenforthetreatmentofrelapsedrefractorybcelllymphomas AT laixun 4scar20amulticarttherapyregimenforthetreatmentofrelapsedrefractorybcelllymphomas AT zhangrui 4scar20amulticarttherapyregimenforthetreatmentofrelapsedrefractorybcelllymphomas AT liuyuchen 4scar20amulticarttherapyregimenforthetreatmentofrelapsedrefractorybcelllymphomas AT qinyue 4scar20amulticarttherapyregimenforthetreatmentofrelapsedrefractorybcelllymphomas AT savchenkovalery 4scar20amulticarttherapyregimenforthetreatmentofrelapsedrefractorybcelllymphomas AT gabeevanelly 4scar20amulticarttherapyregimenforthetreatmentofrelapsedrefractorybcelllymphomas AT chungtsaihua 4scar20amulticarttherapyregimenforthetreatmentofrelapsedrefractorybcelllymphomas AT shengliyuan 4scar20amulticarttherapyregimenforthetreatmentofrelapsedrefractorybcelllymphomas AT changlungji 4scar20amulticarttherapyregimenforthetreatmentofrelapsedrefractorybcelllymphomas |